Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Evidence and Therapeutic Potential

Tekijä Nowak, Kristen L., Hopp, Katharina
Julkaisussa Clin J Am Soc Nephrol (2020)

ROLE OF CHEMOKINES, INNATE AND ADAPTIVE IMMUNITY

Tekijä Zimmerman, Kurt A., Hopp, Katharina, Mrug, Michal
Julkaisussa Cell Signal (2020)

Renal double negative T cells: unconventional cells in search of a function

Tekijä Nemenoff, Raphael A., Kleczko, Emily K., Hopp, Katharina
Julkaisussa Ann Transl Med (2019)

Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner

Tekijä Gainullin, Vladimir G., Hopp, Katharina, Ward, Christopher J., Hommerding, Cynthia J., Harris, Peter C.
Julkaisussa J Clin Invest (2015)

Tolvaptan plus Pasireotide Shows Enhanced Efficacy in a PKD1 Model

Tekijä Hopp, Katharina, Hommerding, Cynthia J., Wang, Xiaofang, Ye, Hong, Harris, Peter C., Torres, Vicente E.
Julkaisussa J Am Soc Nephrol (2015)

Effects of hydration in rats and mice with polycystic kidney disease

Tekijä Hopp, Katharina, Wang, Xiaofang, Ye, Hong, Irazabal, María V., Harris, Peter C., Torres, Vicente E.
Julkaisussa Am J Physiol Renal Physiol (2014)

Inhibition of 5-lipoxygenase decreases renal fibrosis and progression of chronic kidney disease

Tekijä Montford, John R., Bauer, Colin, Dobrinskikh, Evgenia, Hopp, Katharina, Levi, Moshe, Weiser-Evans, Mary, Nemenoff, Raphael, Furgeson, Seth B.
Julkaisussa Am J Physiol Renal Physiol (2019)

Metabolic profiling in children and young adults with autosomal dominant polycystic kidney disease

Tekijä Baliga, Madhurima M., Klawitter, Jost, Christians, Uwe, Hopp, Katharina, Chonchol, Michel, Gitomer, Berenice Y., Cadnapaphornchai, Melissa A., Klawitter, Jelena
Julkaisussa Sci Rep (2021)

Food Restriction Ameliorates the Development of Polycystic Kidney Disease

Tekijä Warner, Gina, Hein, Kyaw Zaw, Nin, Veronica, Edwards, Marika, Chini, Claudia C.S., Hopp, Katharina, Harris, Peter C., Torres, Vicente E., Chini, Eduardo N.
Julkaisussa J Am Soc Nephrol (2016)

A study of sirolimus and mTOR kinase inhibitor in a hypomorphic Pkd1 mouse model of autosomal dominant polycystic kidney disease

Tekijä Holditch, Sara J., Brown, Carolyn N., Atwood, Daniel J., Lombardi, Andrew M., Nguyen, Khoa N., Toll, Harrison W., Hopp, Katharina, Edelstein, Charles L.
Julkaisussa Am J Physiol Renal Physiol (2019)

Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity

Tekijä Hopp, Katharina, Ward, Christopher J., Hommerding, Cynthia J., Nasr, Samih H., Tuan, Han-Fang, Gainullin, Vladimir G., Rossetti, Sandro, Torres, Vicente E., Harris, Peter C.
Julkaistu 2012

Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria

Tekijä Hopp, Katharina, Cogal, Andrea G., Bergstralh, Eric J., Seide, Barbara M., Olson, Julie B., Meek, Alicia M., Lieske, John C., Milliner, Dawn S., Harris, Peter C.
Julkaisussa J Am Soc Nephrol (2015)

Synergistic Genetic Interactions between Pkhd1 and Pkd1 Result in an ARPKD-Like Phenotype in Murine Models

Tekijä Olson, Rory J., Hopp, Katharina, Wells, Harrison, Smith, Jessica M., Furtado, Jessica, Constans, Megan M., Escobar, Diana L., Geurts, Aron M., Torres, Vicente E., Harris, Peter C.
Julkaisussa J Am Soc Nephrol (2019)

Incompletely Penetrant PKD1 Alleles Mimic the Renal Manifestations of ARPKD

Tekijä Vujic, Mihailo, Heyer, Christina M., Ars, Elisabet, Hopp, Katharina, Markoff, Arseni, Örndal, Charlotte, Rudenhed, Bengt, Nasr, Samih H., Torres, Vicente E., Torra, Roser, Bogdanova, Nadja, Harris, Peter C.
Julkaistu 2010

Identification of Gene Mutations in Autosomal Dominant Polycystic Kidney Disease through Targeted Resequencing

Tekijä Rossetti, Sandro, Hopp, Katharina, Sikkink, Robert A., Sundsbak, Jamie L., Lee, Yean Kit, Kubly, Vickie, Eckloff, Bruce W., Ward, Christopher J., Winearls, Christopher G., Torres, Vicente E., Harris, Peter C.
Julkaistu 2012

Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease

Tekijä Rossetti, Sandro, Kubly, Vickie J., Consugar, Mark B., Hopp, Katharina, Roy, Sushmita, Horsley, Sharon W., Chauveau, Dominique, Rees, Lesley, Barratt, T. Martin, Hoff, William G. van't, Niaudet, W. Patrick, Torres, Vicente E., Harris, Peter C.
Julkaistu 2009

B9D1 is revealed as a novel Meckel syndrome (MKS) gene by targeted exon-enriched next-generation sequencing and deletion analysis

Tekijä Hopp, Katharina, Heyer, Christina M., Hommerding, Cynthia J., Henke, Susan A., Sundsbak, Jamie L., Patel, Shail, Patel, Priyanka, Consugar, Mark B., Czarnecki, Peter G., Gliem, Troy J., Torres, Vicente E., Rossetti, Sandro, Harris, Peter C.
Julkaistu 2011

The consequences of increased 4E-BP1 in polycystic kidney disease

Tekijä Holditch, Sara J, Brown, Carolyn N, Atwood, Daniel J, Pokhrel, Deepak, Brown, Sara E, Lombardi, Andrew M, Nguyen, Khoa N, Hill, Ryan C, Lanaspa, Miguel, Hopp, Katharina, Weiser-Evans, Mary C M, Edelstein, Charles L
Julkaisussa Hum Mol Genet (2019)

Inactivation of Tsc2 in Abcg2 lineage-derived cells drives the appearance of polycystic lesions and fibrosis in the adult kidney

Tekijä Gewin, Leslie S., Summers, Megan E., Harral, Julie W., Gaskill, Christa F., Khodo, Stellor Nlandu, Neelisetty, Surekha, Sullivan, Timothy M., Hopp, Katharina, Reese, J. Jeffrey, Klemm, Dwight J., Kon, Valentina, Ess, Kevin C., Shi, Wei, Majka, Susan M.
Julkaisussa Am J Physiol Renal Physiol (2019)

Modulation of Polycystic Kidney Disease Severity by Phosphodiesterase 1 and 3 Subfamilies

Tekijä Ye, Hong, Wang, Xiaofang, Sussman, Caroline R., Hopp, Katharina, Irazabal, Maria V., Bakeberg, Jason L., LaRiviere, Wells B., Manganiello, Vincent C., Vorhees, Charles V., Zhao, Haiqing, Harris, Peter C., van Deursen, Jan, Ward, Christopher J., Torres, Vicente E.
Julkaisussa J Am Soc Nephrol (2016)